Selective serotonin reuptake inhibitor antidepressants: Cardiovascular complications - Sorting through findings

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 467-468

  Shader, R I ^a   Greenblatt, D J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG OVERDOSE; DRUG SAFETY; EDITORIAL; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARDIOVASCULAR DISEASES; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 0034791233     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00001     Document Type: Editorial

References (18)

1. Cardiovascular effects
2. Use of fluoxetine in a person with cardiac arrhythmias
3. Fluoxetine-induced bradycardia and syncope in two patients
4. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease
5. Acquired abnormalities of platelet function
6. Adverse vascular effects associated with fluoxetine [letter]
7. Serum levels and cardiovascular effects of tricyclic antidepressants and selective reuptake inhibitors in depressed patients
8. Platelet-derived serotonin, the endothelium, and cardiovascular disease
9. Platelet cytosolic calcium responses to serotonin in depressed patients and controls: Relationship to symptomatology and medication
10. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors
11. Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors
12. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with the use of tricyclic agents
13. Use of selective serotonin reuptake inhibitors and the risk of developing first-time acute myocardial infarction
14. Psychotropic drug use in the Boston area: A report from the Boston collaborative drug surveillance program
15. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
16. An open-label preliminary trial of sertraline for the treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline anti-depressant heart attack trial
17. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients
18. Efficacy and safety of fluoxetine in the treatment of patients with major depression after acute myocardial infarction: Findings from a double-blind, placebo-controlled trial